ANG Lifesciences IPO vs Nouritrans Exim IPO

Comparison between ANG Lifesciences IPO and Nouritrans Exim IPO.

IPO Details

ANG Lifesciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Nouritrans Exim IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of ANG Lifesciences IPO is up to ₹11.39 Cr whereas the issue size of the Nouritrans Exim IPO is up to ₹5.81 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Nouritrans Exim IPO is ₹30.00 per share.

 ANG Lifesciences IPONouritrans Exim IPO
Face Value₹10 per share₹10 per share
Issue Price (Final)₹80.00 per share₹30.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size1600 shares4000 shares
Fresh Issue Size14,24,000 shares19,36,000 shares
Fresh Issue Size (Amount)up to ₹11.39 Crup to ₹5.81 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total14,24,000 shares19,36,000 shares
Issue Size Total (Amount)up to ₹11.39 Crup to ₹5.81 Cr

IPO Timetable

ANG Lifesciences IPO opens on Aug 29, 2017, while Nouritrans Exim IPO opens on Sep 04, 2017. The closing date of ANG Lifesciences IPO and Nouritrans Exim IPO is Aug 31, 2017, and Sep 07, 2017, respectively.

 ANG Lifesciences IPONouritrans Exim IPO
Issue OpenAug 29, 2017Sep 04, 2017
Issue CloseAug 31, 2017Sep 07, 2017
Basis Of Allotment (Tentative)Sep 12, 2017
Listing date (Tentative)Sep 08, 2017Sep 15, 2017

Financials & KPIs

ANG Lifesciences IPO P/E ratio is , as compared to Nouritrans Exim IPO P/E ratio of .

 ANG Lifesciences IPONouritrans Exim IPO
Financials

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets46.8635.4925.84
Total Income67.9255.1336.94
Profit After Tax2.921.650.40
NET Worth7.594.773.12
Reserves and Surplus3.911.09-0.57
Total Borrowing11.5811.7710.14
Amount in ₹ Crore

Company Financials (Restated)

Period Ended31 Mar 201731 Mar 201631 Mar 2015
Assets8.053.371.04
Total Income11.606.354.18
Profit After Tax0.300.060.05
NET Worth4.430.350.05
Reserves and Surplus2.920.100.04
Total Borrowing0.030.160.06
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)99.94%47.22%
Promoter Shareholding (Post-Issue)71.00%31.42%
Market Cap₹41.47 Cr.₹18.29 Cr.

Shares Offered

In the ANG Lifesciences IPO Retail Individual Investors (RII) are offered 7,12,000 shares while in Nouritrans Exim IPO retail investors are offered 7,12,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in ANG Lifesciences IPO and 0 shares in Nouritrans Exim IPO.

 ANG Lifesciences IPONouritrans Exim IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation76,800 shares1,04,000 shares
QIB0 shares0 shares
NII7,12,000 shares9,68,000 shares
RII7,12,000 shares9,68,000 shares
Employee0 shares0 shares
Total14,24,000 shares19,36,000 shares

Bids Received (Subscription)

ANG Lifesciences IPO subscribed 8.25x in total, whereas Nouritrans Exim IPO subscribed 1.44x.

 ANG Lifesciences IPONouritrans Exim IPO
NII (times)5.13x0.59x
RII (times)11.36x2.30x
Total (times)8.25x1.44x

Compare with others

Compare:

ANG Lifesciences IPO Vs Nouritrans Exim IPO